321
Participants
Start Date
October 31, 2013
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
Tregalizumab
humanized anti-CD4 mAb
Placebo
identical end formulation buffer
Study Site 04, North Charleston
Study Site 05, Jackson
Study Site 01, Springfield
Study Site 03, Lincoln
Study Site 09, Houston
Study Site 10, Katy
Study Site 07, Paradise Valley
Study Site 02, Clifton
Study Site 01, Plovdiv
Study Site 06, Plovdiv
Study Site 02, Sofia
Study Site 04, Sofia
Study Site 07, Sofia
Study Site 05, Stara Zagora
Study Site 03, Varna
Study Site 02, Rimouski
Study Site 01, Saint-Jérôme
Study Site 03, Bruntál
Study Site 05, Ostrava
Study Site 01, Prague
Study Site 04, Prague
Study Site 08, Prague
Study Site 09, Prague
Study Site 02, Uherské Hradiště
Study Site 07, Uherské Hradiště
Study Site 06, Zlín
Study Site 01, Tallinn
Study Site 03, Berlin
Study Site 04, Frankfurt
Study Site 06, München
Study Site 02, Ratingen
Study Site 01, Zerbst
Study Site 03, Balatonfüred
Study Site 02, Budapest
Study Site 04, Budapest
Study Site 05, Budapest
Study Site 06, Gyula
Study Site 01, Veszprém
Study Site 01, Kaunas
Study Site 02, Vilnius
Study Site 06, León
Study Site 05, Mexico City
Study Site 08, Mexico City
Study Site 02, Chihuahua City
Study Site 03, Distrito Federal
Study Site 08, Bialystok
Study Site 05, Bydgoszcz
Study Site 10, Elblag
Study Site 04, Gdynia
Study Site 02, Katowice
Study Site 03, Krakow
Study Site 06, Krakow
Study Site 09, Poznan
Study Site 01, Warsaw
Study Site 07, Warsaw
Study Site 08, Kemerovo
Study Site 11, Kemerovo
Study Site 04, Kursk
Study Site 03, Moscow
Study Site 07, Moscow
Study Site 10, Moscow
Study Site 05, Omsk
Study Site 09, Saratov
Study Site 06, Smolensk
Study Site 01, Tomsk
Study Site 02, Yaroslavl
Study Site 01, Belgrade
Study Site 02, Belgrade
Study Site 04, Belgrade
Study Site 03, Niška Banja
Study Site 03, Bratislava
Study Site 04, Kosice - Saca
Study Site 05, Lučenec
Study Site 02, Považská Bystrica
Study Site 01, Rimavská Sobota
Study Site 08, Donetsk
Study Site 01, Kharkiv
Study Site 02, Kharkiv
Study Site 03, Kyiv
Study Site 04, Kyiv
Study Site 05, Vinnytsia
Study Site 06, Vinnytsia
Study Site 07, Vinnytsia
Study Site 09, Zaporizhzhia